Fifth Third Wealth Advisors LLC Halozyme Therapeutics, Inc. Transaction History
Fifth Third Wealth Advisors LLC
- $1.84 Trillion
- Q4 2024
A detailed history of Fifth Third Wealth Advisors LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Fifth Third Wealth Advisors LLC holds 4,265 shares of HALO stock, worth $266,733. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,265
Previous 4,330
1.5%
Holding current value
$266,733
Previous $248 Million
17.73%
% of portfolio
0.01%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding HALO
# of Institutions
550Shares Held
124MCall Options Held
668KPut Options Held
259K-
Black Rock Inc. New York, NY17.6MShares$1.1 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.3MShares$831 Million0.01% of portfolio
-
State Street Corp Boston, MA7.18MShares$449 Million0.01% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.17MShares$261 Million4.34% of portfolio
-
Bank Of America Corp Charlotte, NC3.45MShares$216 Million0.01% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $8.71B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...